CAS No. |
560130-42-9 |
|---|---|
中文名称 |
盐酸(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-氨基-2-氧代乙基)-10,19-二氯-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(癸基氨基)乙基)氨基)-5-羟基-4,6-二甲基四氢-2H-吡喃-2-基)氧基)-4,5-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-7,22,28,30,32-五羟基-6-((R)-4-甲基-2-(甲基氨基)戊烷酰胺基)-2,5,24,38,39-五氧代-29-(((膦酰甲基)氨基)甲基)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-十四氢-1H,22H-23,36-(氮杂桥甲烷基)-8,11:18,21-二亚乙烯基-13,16:31,35-二(亚甲烯基)苯并[n][1]氧杂[6,9]二氮杂环十六炔并[4,5-d][1]氧杂[7,17]二氮杂环二十四烯-26-羧酸盐酸盐 |
英文名称 |
(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(decylamino)ethyl)amino)-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-7,22,28,30,32-pentahydroxy-6-((R)-4-methyl-2-(methylamino)pentanamido)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)benzo[n][1]oxa[6,9]diazacyclohexadecino[4,5-d][1]oxa[7,17]diazacyclotetracosine-26-carboxylic acid hydrochloride |
别名 |
Telavancin hydrochloride;N3''-[2-(Decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]vancomycin hydrochloride;PubChem ID: 9812715;Telavancin HCl;TelavancinHydrochlorid;Teravanacin hydrochloride;Terafencin hydrochloride |
标准英文名 |
(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(decylamino)ethyl)amino)-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-7,22,28,30,32-pentahydroxy-6-((R)-4-methyl-2-(methylamino)pentanamido)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)benzo[n][1]oxa[6,9]diazacyclohexadecino[4,5-d][1]oxa[7,17]diazacyclotetracosine-26-carboxylic acid hydrochloride |
分子式 |
C80H107Cl3N11O27P |
分子量 |
1792.12 |
精确分子量 |
1789.61 |
SMILES |
CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](OC3=C4C=C5C=C3OC3=C(Cl)C=C(C=C3)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C5=CC(O)=C(CNCP(=O)(O)O)C(O)=C5C5=CC3=CC=C5O)[C@H](O)C3=CC(Cl)=C(C=C3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.Cl |
标准SMILES |
Cl.CC(C)C[C@@H](NC)C(=O)N[C@@H]1[C@H](O)C2C=CC(OC3=CC4=CC(OC5C=CC(=CC=5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C1=CC=C(O)C(=C1)C1C(=CC(O)=C(CNCP(O)(O)=O)C=1O)[C@H](NC5=O)C(O)=O)=C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(NCCNCCCCCCCCCC)[C@H](O)[C@H](C)O1)=C(Cl)C=2 |
用途 |
Telavancin hydrochloride is a bactericidal antibiotic developed specifically for the treatment of serious infections caused by Staphylococcus aureus and other Gram-positive bacteria, with a dual mechanism of action involving inhibition of bacterial cell wall synthesis and disruption of bacterial cell membrane function. It has been approved in the United States and Canada for the treatment of complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including both methicillin-susceptible and methicillin-resistant strains), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus anginosus group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), and Enterococcus faecalis (vancomycin-susceptible isolates only). |
InChIKey |
GSSIWSIRBWAZHG-ACOPVEIWSA-N |
|
|
评论 |
|---|